Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Generics
Sort By
Newest First
1 / 4
1 / 4
CDMO
Maximizing Outsourcing Benefits for Virtual Pharma Companies
William Kazimier
Tedor Pharma Services
PAO-09-23-CL-08
January 11, 2024
CDMO
Redesigning ANDA or Novel Drug Products at All Stages for the U.S. Market
Tedor Pharma Services
PAO-08-23-CL-06
September 26, 2023
Parenterals
Trends Shaping the Dynamic Market for Parenterals
Marga Viñes
Grifols
PAP-Q3-20-CL-018
September 29, 2020
FDA Approval
Perrigo and Catalent Announce FDA Approval of Perrigo's AB-Rated Generic Version of ProAir® HFA
Perrigo
PR-M02-20-NI-041
February 27, 2020
Market Prediction
Popularity of Generic Drugs Poised to Overshadow Atherosclerosis Drugs Market Growth
Transparency Market Research
PR-M01-20-NI-022
January 15, 2020
Generics
Seqens North America Identifies Trends Affecting the Generic Drugs Sector in 2020
SEQENS North America
PR-M01-20-NI-021
January 15, 2020
M&A
ANI Pharmaceuticals Announces Acquisition of Commercial and Pipeline Generic Products from Amerigen Pharmaceuticals, Ltd.
ANI
PR-M01-20-NI-019
January 14, 2020
Generic
Amneal Announces Approval of Generic Version of Amicar®
Amneal
PR-M09-19-NI-024
September 10, 2019
Generics
China Eases Generic Drug Market Shake-Up
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M08-19-NI-001
August 01, 2019
Generics
FDA Approves First Generics of Lyrica
The Food and Drug Administration
PR-M07-19-NI-060
July 23, 2019
FDA Approval
MSN Labs/Novadoz Pharmaceuticals Early Success Continues With FDA Approval Of Generic Abiraterone
Novadoz Pharmaceuticals
PR-M07-19-NI-045-2367
July 17, 2019
Generics
Mallinckrodt Modifies Specialty Generics Spinout Portfolio Composition
Nice Insight
PAO-M06-19-NI-004
June 13, 2019
Generics
Mallinckrodt Updates Plans for Company Separation and Spin-Off of Specialty Generics Business to Shareholders
Mallinckrodt
PR-M05-19-NI-087
May 31, 2019
Generics
State Lawsuit Charges Generic Makers with Price Fixing
Nice Insight
PAO-M05-19-NI-032
May 29, 2019
Generics
Being at the Right Place at the Right Time
Ori Gutwerg
Taro Pharmaceutical Industries
PAP-Q2-2019-CL-033
May 24, 2019
Generics
Teva Announces Launch of a Generic Version of Tarceva® (erlotinib) Tablets in the United States
TEVA
PR-M05-19-NI-045
May 15, 2019
Generic
First Generic Nalaxone Nasal Spray Approved by FDA
Emilie Branch
Pharma's Almanac
PAO-M05-19-NI-006
May 02, 2019
Opioids
FDA Grants Competitive Generic Therapy (CGT) Designation to Purdue Pharma’s Investigational Nalmefene HCl Injection
Purdue Pharma L.P.
PR-M04-19-NI-080
April 25, 2019
Generics
The Generic Pharmaceutical Market in Kenya & Nigeria - Forecast to 2022
Research and Markets
PR-M04-19-NI-079
April 25, 2019
Generics
Teva Announces Launch of a Generic Version of VESIcare® (solifenacin succinate) Tablets in the United States
TEVA
PR-M04-19-NI-072
April 23, 2019
